January 2024
This survey provides a uniquely large individual-level dataset from which to evaluate the effectiveness, user profile, and comparative performance of the DR.VEGAN® Daily Multivitamin against the broader multivitamin market. This abstract reports individual-level user-reported outcomes for the DR.VEGAN® Daily Multivitamin across overall wellbeing, twelve domain-specific health areas, value for money, comparative effectiveness, and user behaviour, with direct comparison to aggregate findings across all multivitamin brands assessed in this survey. The survey was conducted by DR.VEGAN®, January 2024.
The DR.VEGAN® Daily Multivitamin user subgroup (n=138) was identified from a full multivitamin-taker cohort (n=343) by individual-level response to the brand question. All effectiveness, value, comparative, and usage analyses were repeated for this subgroup and directly compared with figures from the full multivitamin-taker cohort. Domain-specific effectiveness was assessed across twelve areas on a five-point scale (extremely effective, somewhat effective, not so effective, completely ineffective, unsure). Overall wellbeing effectiveness was rated on a five-point scale (extremely effective through not at all effective). All analyses are based on individual-level data.
138 respondents currently took the DR.VEGAN® Daily Multivitamin (47.8% of all multivitamin users; 21.2% of the total survey sample). 61.4% started primarily to improve overall wellbeing, 40.2% for more energy, 50.8% to fill dietary gaps, and 32.6% because of a vegan or vegetarian diet, notably higher than the all-MV-users figure for this motivation (26.7%), reflecting DR.VEGAN’s positioning within plant-based communities. Brand selection was driven by existing brand familiarity (37.9%), friend recommendation (17.4%), Google search (17.4%), and social media advertising (15.2%). 74.2% had read the ingredients list on their current product; 55.3% had checked for and confirmed the absence of unnecessary additives, compared with 47.0% across all multivitamin users.
DR.VEGAN® Daily Multivitamin users reported substantially stronger overall wellbeing effectiveness than the broader multivitamin market. Of 131 DR.VEGAN® users who rated their product, 98.5% gave a combined positive rating (extremely effective: 17.6%, very effective: 38.2%, somewhat effective: 42.7%) compared with 94.4% across all multivitamin brands. Notably, the highly positive rate (extremely + very effective) was 55.7% for DR.VEGAN®, compared with 46.4% across all brands - a difference of 9.3 percentage points. The combined negative rate for DR.VEGAN® was just 1.5%, versus 5.6% across all brands. See Figure 1.
| Overall wellbeing | n | % |
|---|---|---|
| Extremely effective | 23 | 17.6% |
| Very effective | 50 | 38.2% |
| Combined positive | 129 | 98.5% |
| Not so / not at all | 2 | 1.5% |
| Highly positive (ext+very) | 73 | 55.7% |
| Overall wellbeing | n | % |
|---|---|---|
| Extremely effective | 34 | 12.7% |
| Very effective | 90 | 33.7% |
| Combined positive | 252 | 94.4% |
| Not so / not at all | 15 | 5.6% |
| Highly positive (ext+very) | 124 | 46.4% |
DR.VEGAN® users rated their product as more effective than the all-brand average across every one of the twelve domains assessed. The largest differentials were for brain fog (+7.4 percentage points positive vs all brands: DR.VEGAN 48.0% vs all 40.6%), concentration (+5.1pp: 48.8% vs 43.7%), moods (+4.7pp: 50.4% vs 45.7%), skin (+3.6pp: 56.0% vs 52.4%), and sleep (+3.4pp: 40.0% vs 36.6%). The largest absolute positive rates for DR.VEGAN® were immunity (69.6%), energy (57.6%), skin (56.0%), moods (50.4%), nails (51.2%), and concentration (48.8%). See Figure 2.
| Health domain | DR.VEGAN® | All MV | Diff (pp) |
|---|---|---|---|
| Immunity | 69.6% | 67.8% | +1.8pp |
| Energy | 57.6% | 55.3% | +2.3pp |
| Skin | 56.0% | 52.4% | +3.6pp |
| Nails | 51.2% | 48.9% | +2.3pp |
| Moods | 50.4% | 45.7% | +4.7pp |
| Concentration | 48.8% | 43.7% | +5.1pp |
| Brain fog | 48.0% | 40.6% | +7.4pp |
| Sleep | 40.0% | 36.6% | +3.4pp |
| Hair | 38.4% | 37.1% | +1.3pp |
| Bones & joints | 37.6% | 35.9% | +1.7pp |
| Digestion | 33.6% | 32.3% | +1.3pp |
| Stress | 31.2% | 29.8% | +1.4pp |
| Weight management | 22.4% | 21.1% | +1.3pp |
87 of 138 DR.VEGAN® users (63.0%) had previously taken a different multivitamin brand before switching to DR.VEGAN®. The most commonly abandoned brands were Inessa (42.5%), Wild Nutrition (37.9%), Centrum (31.0%), Solgar (17.2%), supermarket own brands (14.9%), and Terranova (9.2%). Among those who had switched, the primary reasons for stopping their previous brand were that it didn’t work (32.2%), the presence of unnecessary additives (27.6%), cost (24.1%), and missing the right ingredients (19.5%). The notably higher rate of additive-driven switching among DR.VEGAN® users (27.6%) versus all switchers (18.7%) suggests that ingredient quality and additive avoidance are above-average priorities for this user group.
Of 125 DR.VEGAN® users who had tried other multivitamins, 48.8% rated DR.VEGAN as more effective (32.8% much more, 16.0% a little more) versus 43.2% across all current multivitamin users who made the same comparison. 88.8% of DR.VEGAN® users considered the product to represent value for money (33.6% yes, a lot; 55.2% yes, a little), compared with 81.6% across all brands. Only 11.2% of DR.VEGAN® users felt it was poor or no value, versus 18.4% overall.
56.0% of DR.VEGAN® users reported feeling different when they had not taken their multivitamin for a few days, compared with 53.2% overall. 75.2% believed DR.VEGAN® protected them when their diet was not as healthy as it should be, compared with 65.6% across all brands - a 9.6 percentage point differential, suggesting stronger perceived nutritional reassurance among DR.VEGAN® users.
70.4% of DR.VEGAN® users noticed benefit within four weeks, virtually identical to the all-brand figure of 70.1%, indicating that onset profile is comparable across products. The distribution within four weeks was slightly front-loaded for DR.VEGAN®, with 24.0% noticing benefit at 2–3 weeks compared with 20.5% overall.
84.4% of DR.VEGAN® users took at least one additional supplement, with mental health (27.0%), hair, skin, and nails (29.5%), PMS (21.3%), eyes (21.3%), and heart health (19.7%) as the most common supplementary goals - a profile consistent with DR.VEGAN’s broader, engaged, health-conscious customer base.
Based on user-reported outcomes, individual-level analysis of this survey demonstrates that the DR.VEGAN® Daily Multivitamin outperforms the broader multivitamin market across every effectiveness measure assessed. Its combined positive overall wellbeing effectiveness of 98.5% compares with 94.4% across all brands; its highly positive rate (55.7%) exceeds the all-brand figure by 9.3 percentage points; and it achieves consistently higher domain-specific effectiveness across all twelve health areas, with the most pronounced advantages in brain fog (+7.4pp), concentration (+5.1pp), moods (+4.7pp), and skin (+3.6pp). Users perceive stronger protective value (75.2% vs 65.6%) and greater value for money (88.8% vs 81.6%). An additive-free formulation is a meaningful driver of switching to DR.VEGAN, with 27.6% of switchers citing unnecessary additives in their previous brand as a reason for leaving, a higher rate than seen across all switchers (18.7%). These findings collectively position the DR.VEGAN® Daily Multivitamin as a superior-performing product within the current multivitamin market, with a particularly strong effectiveness profile for cognitive and mood-related health domains.
Keywords: DR.VEGAN®, daily multivitamin, wellbeing, brain fog, energy, immunity, additive-free, comparative effectiveness, user-reported outcomes, dietary supplement
Survey date: 2024 | DR.VEGAN® users: N = 138 | All MV users: N = 343 | Total respondents: N = 651
Media enquiries: Please contact [email protected]
Your shopping basket is empty. Need some help?
Our Virtual Nutritionist is here to assist you.
Subtotal
£0.00
Shipping and taxes calculated at checkout.
